Mechanisms controlling sensitivity to platinum complexes: role of p53 and DNA mismatch repair
S Manic, L Gatti, N Carenini… - Current cancer drug …, 2003 - ingentaconnect.com
Although cisplatin is effective in the treatment of different types of tumors, resistance to
treatment is a major limitation. In an attempt of overcoming resistance mechanisms, a large …
treatment is a major limitation. In an attempt of overcoming resistance mechanisms, a large …
Mechanisms controlling sensitivity to platinum complexes: role of p53 and DNA mismatch repair.
S Manic, I Gatti, N Carenini, GF Fumagalli… - CURRENT CANCER …, 2003 - iris.univr.it
Although cisplatin is effective in the treatment of different types of tumors, resistance to
treatment is a major limitation. In an attempt of overcoming resistance mechanisms, a large …
treatment is a major limitation. In an attempt of overcoming resistance mechanisms, a large …
Mechanisms controlling sensitivity to platinum complexes: role of p53 and DNA mismatch repair.
S Manic, L Gatti, N Carenini, G Fumagalli… - Current Cancer Drug …, 2003 - europepmc.org
Although cisplatin is effective in the treatment of different types of tumors, resistance to
treatment is a major limitation. In an attempt of overcoming resistance mechanisms, a large …
treatment is a major limitation. In an attempt of overcoming resistance mechanisms, a large …
Mechanisms controlling sensitivity to platinum complexes: role of p53 and DNA mismatch repair
S Manic, L Gatti, N Carenini… - … cancer drug targets, 2003 - pubmed.ncbi.nlm.nih.gov
Although cisplatin is effective in the treatment of different types of tumors, resistance to
treatment is a major limitation. In an attempt of overcoming resistance mechanisms, a large …
treatment is a major limitation. In an attempt of overcoming resistance mechanisms, a large …